slides · global inventory
Other
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 19,048
Current window 8,731-8,760
Pages 635
Rows per page 30
Slide type
8,731-8,760 of 19,048
04
The slide uses a stylized wireframe human body to illustrate the systemic presence of iNKT cells.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
05
The slide uses a simple linear process flow to explain the manufacturing and administration of off-the-shelf cell therapies.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
09
Source: Rahib et al, JAMA Net 2021Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · Problem Statement1 hit
10
Uses a temple pillar metaphor to represent the evolution of cancer treatment options.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · Problem Statement1 hit
11
Source: Collisson et al, Nat Can Rev 2019Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
12
The diagram contrasts the state of T cell inhibition (left) with T cell activation (right) via therapeutic antibodies.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
15
Source: Weber et al, Cell 2020Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
22
The slide uses a biological process diagram to explain the mechanism of action for iNKT cells.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · Proposed SolutionLoop · Logic Chain1 hit
24
The diagram depicts a biological process flow involving iNKT cells, DCs, MDSCs, and inflammatory monocytes.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
33
The slide uses a staircase diagram to represent dose escalation levels.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
41
Illustrates the mechanism of action for two distinct therapeutic modalities.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
42
The diagram illustrates the interaction between iNKT cells and tumor cells/immune cells via various receptors (CAR, iTCR, NKG2D, DNAM1).Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
47
The diagram shows the interaction between tumor cell receptors and iNKT cell receptors, including the secretion of IL15.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
55
The slide illustrates the CARDIS platform workflow and the resulting distribution of binders vs non-binders.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
66
The slide uses a combination of medical illustration and real-world clinical photography to explain the procedure.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
82
The slide depicts a mechanism of immune evasion via metabolic competition and immunosuppressive signaling.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
85
The slide depicts a xenograft model setup.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
89
Scientific visualization of immune cell behavior in adipose tissue.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
90
Data from Lynch et al. Nature Immunology 2015 and Lynch et al. Immunity 2012.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
06
The slide uses a before-and-after visual comparison to demonstrate efficiency gains.NextNav | Mergers and Acquisitions Presentation Deck | 9 slides · NextNav
Deck Investment bank Beat · Market Size and OpportunityLoop · Cost Of Inaction1 hit
08
NextNav | Mergers and Acquisitions Presentation Deck | 9 slidesNextNav | Mergers and Acquisitions Presentation Deck | 9 slides · NextNav
Deck Investment bank Beat · Transaction Terms1 hit
07
The slide categorizes financial incentives into three pillars: Production, Dispensing, and Truck.Nikola | Results Presentation Deck | 20 slides · Nikola
Conference presentation Investor relations Beat · EvidenceLoop · Golden Circle1 hit
09
Includes photos of the facility and production line, with blue dashed outlines indicating the expansion area.Nikola | Results Presentation Deck | 20 slides · Nikola
Conference presentation Investor relations Beat · EvidenceLoop · Golden Circle1 hit
17
This appears to be a satirical or placeholder slide, as the content is a brand advertisement rather than financial data.Oatly | Results Presentation Deck | 33 slides · Oatly
Conference presentation Investor relations Beat · Satisfaction1 hit
17
The slide highlights social proof through a logo grid of 16 major pharmaceutical and biotech companies.OmniAb | Investor Conference Presentation Deck | 27 slides · OmniAb
Conference presentation Investor relations 1 hit
21
OmniAb | Investor Conference Presentation Deck | 27 slidesOmniAb | Investor Conference Presentation Deck | 27 slides · OmniAb
Conference presentation Investor relations 1 hit
07
The slide uses a process flow framework to categorize proprietary technologies into three distinct stages of the antibody discovery pipeline.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide illustrates the genetic engineering process of replacing endogenous Ig genes with human V gene segments while retaining rodent constant regions for immune robustness.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
Uses a phylogenetic tree to justify the use of avian species for antibody production based on evolutionary divergence.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide compares human and cow antibody structures, specifically focusing on the 'knob-and-stalk' architecture of the ultralong CDRH3.OmniAb | Investor Conference Presentation Deck | 43 slides · OmniAb
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit